Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (191-200 of 314) with videos related to

Pageof 32
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 5, 2019
Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033Linda Dirven, Jaap C Reijneveld, Martin J B Taphoorn, et al.
BMC Cancer|October 21, 2016
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trialPerparim Limani, Michael Linecker, Philipp Kron, et al.
The Lancet. Oncology|February 1, 2014
Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trialsEfstathios Zikos, Irina Ghislain, Corneel Coens, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
High Dimensional Proteomic Multiplex Imaging of the Central Nervous System Using the COMET<sup>™</sup> SystemHinda Najem, Sebastian Pacheco, Jillyn Turunen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancerMarkus M Borner, Daniel Dietrich, Roger Stupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trialRené-Olivier Mirimanoff, Thierry Gorlia, Warren Mason, et al.
Neuro-Oncology|June 7, 2011
The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescenceWanyu L Lambiv, Irene Vassallo, Mauro Delorenzi, et al.
BMC Cancer|April 25, 2024
A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physiciansPriya Kumthekar, Madison Lyleroehr, Leilani Lacson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomideRoger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic, et al.
Acta Neuropathologica Communications|March 25, 2022
DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patientsPierre Bady, Christine Marosi, Michael Weller, et al.
Pageof 32

Showing results (191-200 of 314) with videos related to

Sort By:
Pageof 32
International Journal of Radiation Oncology, Biology, Physics|February 5, 2019
Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033Linda Dirven, Jaap C Reijneveld, Martin J B Taphoorn, et al.
BMC Cancer|October 21, 2016
Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trialPerparim Limani, Michael Linecker, Philipp Kron, et al.
The Lancet. Oncology|February 1, 2014
Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trialsEfstathios Zikos, Irina Ghislain, Corneel Coens, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
High Dimensional Proteomic Multiplex Imaging of the Central Nervous System Using the COMET<sup>™</sup> SystemHinda Najem, Sebastian Pacheco, Jillyn Turunen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancerMarkus M Borner, Daniel Dietrich, Roger Stupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trialRené-Olivier Mirimanoff, Thierry Gorlia, Warren Mason, et al.
Neuro-Oncology|June 7, 2011
The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescenceWanyu L Lambiv, Irene Vassallo, Mauro Delorenzi, et al.
BMC Cancer|April 25, 2024
A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physiciansPriya Kumthekar, Madison Lyleroehr, Leilani Lacson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomideRoger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic, et al.
Acta Neuropathologica Communications|March 25, 2022
DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patientsPierre Bady, Christine Marosi, Michael Weller, et al.
Pageof 32